NCT02832375View on ClinicalTrials.gov

Investigating the Efficacy of an Occluding Dentifrice in Providing Relief From Dentinal Hypersensitivity

PHASE3CompletedINTERVENTIONAL
Enrollment

242

Participants

Timeline

Start Date

March 1, 2016

Primary Completion Date

May 1, 2016

Study Completion Date

May 12, 2016

Conditions
Dentin Sensitivity
Interventions
DRUG

stannous fluoride

0.454% w/w stannous fluoride containing 1100ppm of fluoride

DRUG

sodium monofluorophosphate

0.76% w/w sodium monofluorophosphate containing 1000ppm fluoride

Trial Locations (1)

89146

GSK Investigational Site, Las Vegas

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT02832375 - Investigating the Efficacy of an Occluding Dentifrice in Providing Relief From Dentinal Hypersensitivity | Biotech Hunter | Biotech Hunter